Xuhan Zhang
机构:University of Science and Technology of China
发表论文 8 篇 · 总被引 23 次 · h-index 3
代表论文
- IL-10 Expressing CD19 CAR-T Cells Induce Complete Remission and Improve Long-Term Protection in Relapsed or Refractory B-Cell Hematological Malignancies (2024 · Blood · 被引 13)
- CD19-targeted chimeric antigen receptor-modified T cells induce remission in patients with relapsed acute B lymphoblastic leukemia after umbilical cord blood transplantation (2021 · Chinese Medical Journal · 被引 6)
- IL-10-expressing, anti-CD19 CAR T cells for patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: an open-label, single-arm, phase 1 study (2025 · The Lancet Haematology · 被引 4)
- Charting the landscape and evolution of research on cell death in acute lymphoblastic leukemia: a comprehensive bibliometric analysis (1990–2024) (2025 · Discover Oncology)
- CT-244 Updated Clinical Progress of IL-10 expressing CD19 CAR-T Cells for Treatment of Relapsed or Refractory B-Cell Hematological Malignancies at Tiny Doses (2024 · Clinical Lymphoma Myeloma & Leukemia)
- Updated Clinical Progress of IL-10 expressing CD19 CAR-T Cells for Treatment of Relapsed or Refractory B-Cell Hematological Malignancies at Tiny Doses (2024 · Clinical Lymphoma Myeloma & Leukemia)